The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Liquid biopsy testing in lung cancer

Name: Liquid biopsy testing in lung cancer
Uploaded: 2020-01-30T00:00:00Z
Duration: 1 min 38 s
Description: Neal Navani, MA, MRCP, MSc, PhD, Care Quality Improvement Department, Royal College of Physicians, London, UK, discusses the use of liquid biopsy testing in lung cancer. Dr Nanani goes on to outline the limitations of the technique compared to standard biopsy. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Neal Navani • 30 Jan 2020

BTOG 2020

General Lung Cancer

Neal Navani, MA, MRCP, MSc, PhD, Care Quality Improvement Department, Royal College of Physicians, London, UK, discusses the use of liquid biopsy testing in lung cancer. Dr Nanani goes on to outline the limitations of the technique compared to standard biopsy. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.